NCT00003136View on ClinicalTrials.gov

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

December 31, 2000

Study Completion Date

October 31, 2001

Conditions
Ovarian CancerPrimary Peritoneal Cavity Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

amifostine trihydrate

DRUG

carboplatin

DRUG

cyclophosphamide

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

60637

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT00003136 - Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter